Tranzactioneaza Arca Biopharma Inc (US.ABIO) - 2.46 USD (%) Tranzactioneaza

1D
1W
1M
3M
6M
1Y
5Y
Max

Indici

Bid 2.2800 USD
Ask 2.5000 USD
Minim 2.3200 USD
Maxim 2.3600 USD
Pret referinta 2.4600
Volum -
Volum ultima zi 1
Max 52 sapt 29.6400 USD
Min 52 sapt 1.5600 USD

Descriere companie

ARCA biopharma, Inc. (ARCA) (http://arcabio.com/) is a biopharmaceutical company. The Company is focused on development and commercialization of targeted therapies for cardiovascular diseases. The Company's lead product includes Recombinant Nematode Anticoagulant Protein c2, or rNAPc2 (AB201) and Gencaro(bucindolol hydrochloride). rNAPc2 (AB201) is a treatment for diseases caused by ribonucleic acid (RNA), viruses, focusing on COVID-19, the disease syndrome caused by the SARS-CoV-2 virus. Gencaro(bucindolol hydrochloride) is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties for the treatment of atrial fibrillation (AF) in patients with heart failure. AF is the form of cardiac arrhythmia, a disruption of the heart’s normal rhythm or rate. The Company is conducting Phase II b clinical trial of rNAPc2 (AB201), ASPEN-COVID-19. It is also conducting Phase IIB/III clinical trial of Gencaro.

Informatii companie

Nume

ARCA BIOPHARMA INC